With proper funding, the aim is within the next 5-10 years to:
- Identify early and novel biomarkers for atherosclerosis suitable for screening in high-risk population including children with familial hypercholesterolemia
- Complete dietary intervention trials to document effects on relevant biomarkers of disease.